• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者细胞因子风暴期的嗜酸性粒细胞水平、中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值。

Eosinophil Levels, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in the Cytokine Storm Period of Patients with COVID-19.

机构信息

Bursa City Hospital, Pulmonary Medicine Clinic, Bursa, Turkey.

Bursa City Hospital Medical Biochemistry, Bursa, Turkey.

出版信息

Int J Clin Pract. 2022 Aug 3;2022:7450739. doi: 10.1155/2022/7450739. eCollection 2022.

DOI:10.1155/2022/7450739
PMID:35950101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9346569/
Abstract

BACKGROUND

In the early stages of the COVID-19 pandemic, elevated inflammatory cytokine levels, particularly interleukin-6 (IL-6), were detected in patients with cytokine storm (CS).

AIMS

This study aimed to investigate levels, diagnostic usefulness, and optimal cutoff values of monocyte, eosinophil, neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) in CS of patients with COVID-19 and also to identify risk factors for mortality.

METHODS

Seventy-six patients with COVID-19 who developed CS and randomly chosen 150 COVID-19 patients who had no CS during their stay in the hospital were included in the study.

RESULTS

Lymphocytes and eosinophil levels remained lower in the CS group. Patients with low lymphocyte levels had a higher risk for mortality (OR: 1.92). Neutrophil, D-dimer, ferritin, IL-6, NLR, and PLR were higher in the CS group. High levels of neutrophil, ferritin, D-dimer, and NLR and a history of coronary artery disease (CAD) and diabetes mellitus (DM) were identified as independent risk factors for mortality.

CONCLUSION

In the light of the obtained results, COVID-19 patients with a decrease in lymphocyte levels and an increase in NLR and D-dimer levels and a history of CAD and DM have a higher risk of cytokine storm and mortality.

摘要

背景

在 COVID-19 大流行的早期阶段,细胞因子风暴(CS)患者的炎症细胞因子水平升高,特别是白细胞介素 6(IL-6)。

目的

本研究旨在探讨 COVID-19 患者 CS 中单核细胞、嗜酸性粒细胞、中性粒细胞-淋巴细胞比值(NLR)和血小板-淋巴细胞比值(PLR)的水平、诊断有用性和最佳截断值,并确定死亡率的危险因素。

方法

纳入了 76 例 COVID-19 患者发生 CS 以及随机选择的 150 例 COVID-19 患者在住院期间未发生 CS 的患者。

结果

CS 组的淋巴细胞和嗜酸性粒细胞水平仍然较低。淋巴细胞水平较低的患者死亡率较高(OR:1.92)。CS 组的中性粒细胞、D-二聚体、铁蛋白、IL-6、NLR 和 PLR 水平较高。高水平的中性粒细胞、铁蛋白、D-二聚体和 NLR 以及冠状动脉疾病(CAD)和糖尿病(DM)病史被确定为死亡率的独立危险因素。

结论

根据研究结果,淋巴细胞水平降低、NLR 和 D-二聚体水平升高以及 CAD 和 DM 病史的 COVID-19 患者发生细胞因子风暴和死亡率的风险较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7023/9346569/8152b5bace75/IJCLP2022-7450739.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7023/9346569/644a06932217/IJCLP2022-7450739.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7023/9346569/8152b5bace75/IJCLP2022-7450739.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7023/9346569/644a06932217/IJCLP2022-7450739.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7023/9346569/8152b5bace75/IJCLP2022-7450739.002.jpg

相似文献

1
Eosinophil Levels, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in the Cytokine Storm Period of Patients with COVID-19.COVID-19 患者细胞因子风暴期的嗜酸性粒细胞水平、中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值。
Int J Clin Pract. 2022 Aug 3;2022:7450739. doi: 10.1155/2022/7450739. eCollection 2022.
2
Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和嗜酸性粒细胞与淋巴细胞比值(ELR)作为慢性阻塞性肺疾病急性加重(AECOPD)患者的生物标志物。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 23;19:501-518. doi: 10.2147/COPD.S447519. eCollection 2024.
3
Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.常规实验室检测对预测 SARS-CoV-2 感染者死亡和病情恶化为重症或危重症 COVID-19 的准确性。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015050. doi: 10.1002/14651858.CD015050.pub2.
4
Assessment of the relationship between hematologic parameters, (CPD), in screening for COVID-19 severity in women.评估血液学参数(CPD)与女性新冠病毒疾病严重程度筛查之间的关系。
Future Sci OA. 2025 Dec;11(1):2540749. doi: 10.1080/20565623.2025.2540749. Epub 2025 Aug 2.
5
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
6
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)作为慢性阻塞性肺疾病急性加重诊断评估的生物标志物:一项回顾性观察研究
Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024.
7
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study.中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)作为COVID-19疾病的预后标志物,与免疫抑制状态无关:一项病例对照回顾性单中心研究。
Pathogens. 2025 Jun 1;14(6):550. doi: 10.3390/pathogens14060550.
8
Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical Trials.用古塞库单抗治疗斑块状银屑病可降低以中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值和单核细胞/淋巴细胞比值衡量的全身炎症负担:三项随机临床试验的事后分析
Dermatology. 2025 Apr 10:1-15. doi: 10.1159/000545148.
9
A retrospective analysis from NHANES 2003-2018 on the associations between inflammatory markers and coronary artery disease, all-cause mortality and cardiovascular mortality.一项基于2003 - 2018年美国国家健康与营养检查调查(NHANES)的回顾性分析,探究炎症标志物与冠状动脉疾病、全因死亡率和心血管死亡率之间的关联。
PLoS One. 2025 Jul 9;20(7):e0326953. doi: 10.1371/journal.pone.0326953. eCollection 2025.
10
Association between neutrophil-lymphocyte ratio levels and mortality related to cardiovascular cause and all causes in coronary artery disease patients with low-density lipoprotein cholesterol below 1.4 mmol/L: A multicenter cohort study.低密度脂蛋白胆固醇低于1.4 mmol/L的冠心病患者中性粒细胞与淋巴细胞比值水平与心血管病因及全因死亡率的关系:一项多中心队列研究。
Nutr Metab Cardiovasc Dis. 2025 Sep;35(9):104058. doi: 10.1016/j.numecd.2025.104058. Epub 2025 Apr 11.

引用本文的文献

1
COVID-19 Pneumonia and Cytokine Storm Syndrome.新型冠状病毒肺炎及细胞因子风暴综合征
Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.
2
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves.循环CD169+单核细胞的持续存在和HLA-DR下调突显了新冠后综合征(PASC)个体的免疫反应受损:不同新冠疫情浪潮的潜在影响。
Curr Res Microb Sci. 2023 Dec 12;6:100215. doi: 10.1016/j.crmicr.2023.100215. eCollection 2024.
3
Antidiabetic Treatment before Hospitalization and Admission Parameters in Patients with Type 2 Diabetes, Obesity, and SARS-CoV-2 Viral Infection.

本文引用的文献

1
A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID-19 infection.一项评估嗜酸性粒细胞计数作为 COVID-19 感染患者预后评估标志物的作用的研究。
Ann Afr Med. 2022 Jul-Sep;21(3):278-282. doi: 10.4103/aam.aam_41_21.
2
Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma.血液生物标志物作为临床T1N0期食管鳞状细胞癌病理淋巴结转移的预测指标
Dis Esophagus. 2022 Dec 31;36(1). doi: 10.1093/dote/doac042.
3
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia.
2型糖尿病、肥胖症和SARS-CoV-2病毒感染患者住院前的抗糖尿病治疗及入院参数
J Pers Med. 2023 Feb 23;13(3):392. doi: 10.3390/jpm13030392.
4
D-dimer levels and characteristics of lymphocyte subsets, cytokine profiles in peripheral blood of patients with severe COVID-19: A systematic review and meta-analysis.重症新型冠状病毒肺炎患者外周血D-二聚体水平、淋巴细胞亚群特征及细胞因子谱:一项系统评价和荟萃分析
Front Med (Lausanne). 2022 Oct 5;9:988666. doi: 10.3389/fmed.2022.988666. eCollection 2022.
5
White Blood Cells, COVID-19, and Mendelian Randomization.白细胞、新冠病毒与孟德尔随机化
J Pers Med. 2022 Aug 31;12(9):1425. doi: 10.3390/jpm12091425.
中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对急性肢体缺血患者预后预测的影响
Life (Basel). 2022 May 31;12(6):822. doi: 10.3390/life12060822.
4
Synovial Fluid and Serum Neutrophil-to-Lymphocyte Ratio: Novel Biomarkers for the Diagnosis and Prognosis of Native Septic Arthritis in Adults.滑液和血清中性粒细胞与淋巴细胞比值:成人原发性化脓性关节炎诊断和预后的新生物标志物。
J Bone Joint Surg Am. 2022 Sep 7;104(17):1516-1522. doi: 10.2106/JBJS.21.01279. Epub 2022 Jun 20.
5
A study to evaluate the role of eosinophil count as a prognostic marker for assessing the outcome in patients with COVID 19 infection.一项评估嗜酸性粒细胞计数作为 COVID-19 感染患者预后评估标志物的作用的研究。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
6
Neutrophil Lymphocyte Ratio, Monocyte Lymphocyte Ratio, Platelet Lymphocyte Ratio in Covid-19 Patients.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值、血小板与淋巴细胞比值与新型冠状病毒肺炎患者的关系。
Clin Lab. 2022 Mar 1;68(3). doi: 10.7754/Clin.Lab.2021.210639.
7
Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19.中性粒细胞和淋巴细胞有助于区分无症状 COVID-19 和轻症 COVID-19。
Front Cell Infect Microbiol. 2021 Oct 15;11:654272. doi: 10.3389/fcimb.2021.654272. eCollection 2021.
8
Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection.白细胞介素-6、白细胞介素-8/CXCL8、干扰素诱导蛋白 10/CXCL10 水平对 COVID-19 感染严重程度的影响。
Int J Clin Pract. 2021 Dec;75(12):e14970. doi: 10.1111/ijcp.14970. Epub 2021 Oct 22.
9
Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study.新型冠状病毒病 2019 与外周血嗜酸性粒细胞计数:一项回顾性研究。
Infection. 2021 Dec;49(6):1325-1329. doi: 10.1007/s15010-021-01710-w. Epub 2021 Oct 8.
10
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.新冠病毒病危重症患者中的白细胞介素-6受体拮抗剂。回复
N Engl J Med. 2021 Sep 16;385(12):1147-1149. doi: 10.1056/NEJMc2108482. Epub 2021 Aug 18.